Fundraising Fox
Acadia Pharmaceuticals
1,054 employees on LinkedIn · 2 known investors
Find your way into Acadia Pharmaceuticals
Sign up to see every warm intro you have to Acadia Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Acadia Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Acadia is a biopharmaceutical company developing therapies for underserved neurological disorders and rare diseases. The company operates across North America and Europe, leveraging expertise in areas including Parkinson's disease psychosis and Rett syndrome.
Investors · 2
Founder mafia
2 people who came through Acadia Pharmaceuticals went on to found or lead other companies.
Frequently asked questions
- What does Acadia Pharmaceuticals do?
- Acadia is a biopharmaceutical company developing therapies for underserved neurological disorders and rare diseases. The company operates across North America and Europe, leveraging expertise in areas including Parkinson's disease psychosis and Rett syndrome.
- Who are Acadia Pharmaceuticals's investors?
- Acadia Pharmaceuticals's investors include New Enterprise Associates (NEA), Forbion.